Article
- The EMBO Journal (2003) 22, 4748 - 4758
- doi:10.1093/emboj/cdg470
Subject Categories:
An mSin3A interaction domain links the transcriptional activity of KLF11 with its role in growth regulation
Martin E. Fernandez-Zapico1, Ann Mladek1, Volker Ellenrieder1, Emma Folch-Puy1, Laurence Miller2 and Raul Urrutia1,2,3
- Gastroenterology Research Unit, Saint Mary's Hospital, Rochester, MN 55905, USA
- Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN 55905, USA
- Tumor Biology Program, Mayo Clinic, Rochester, MN 55905, USA
Correspondence to:
Raul Urrutia, E-mail: urrutia.raul@mayo.edu
Received 2 April 2003; Accepted 28 July 2003; Revised 14 July 2003
Abstract
KLF11 is a biochemical paradigm for a subset of proteins that repress transcription via a Mad1-like mSin3A interacting domain (SID). The biological role of these proteins and the significance of their biochemical activity, however, remain to be established. We report that KLF11 is downregulated in human cancers, inhibits cell growth in vitro and in vivo, and suppresses neoplastic transformation. Transgenic mice for KLF11 display a downregulation of genes encoding the oxidative stress scavengers SOD2 and Catalase1. Chromatin immunoprecipitation assays confirm that, indeed, these genes are bonafide targets of KLF11. KLF11 expression renders cells more sensitive to oxidative drugs, an effect that is rescued by infection with recombinant adenoviruses expressing SOD2 and Catalase1. KLF11-regulated functions require the Mad1-like SID, indicating that these target genes involved in these phenomena are regulated via this corepressor system. These results demonstrate that SID-containing KLF repressor proteins can inhibit cell growth and neoplastic transformation, and outline for the first time cellular and molecular mechanisms by which these functions may be achieved.
Keywords:
- apoptosis,
- cell growth,
- KLF11,
- mSin3A,
- SID



